National Pension Service lifted its holdings in Amrize Ltd (NYSE:AMRZ – Free Report) by 7.5% during the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,493,022 shares of the company’s stock after acquiring an additional 103,962 shares during the period. National Pension Service owned approximately 0.27% of Amrize worth $79,578,000 as of its most recent filing with the SEC.
A number of other hedge funds have also bought and sold shares of the business. Caldwell Sutter Capital Inc. grew its position in shares of Amrize by 11.5% during the 1st quarter. Caldwell Sutter Capital Inc. now owns 2,675 shares of the company’s stock worth $150,000 after purchasing an additional 275 shares in the last quarter. Rothschild Investment LLC boosted its stake in shares of Amrize by 4.3% in the fourth quarter. Rothschild Investment LLC now owns 6,835 shares of the company’s stock valued at $370,000 after buying an additional 280 shares during the period. Baldwin Investment Management LLC boosted its stake in shares of Amrize by 4.4% in the fourth quarter. Baldwin Investment Management LLC now owns 8,980 shares of the company’s stock valued at $486,000 after buying an additional 375 shares during the period. Mengis Capital Management Inc. grew its position in Amrize by 8.5% during the fourth quarter. Mengis Capital Management Inc. now owns 5,750 shares of the company’s stock worth $311,000 after buying an additional 450 shares in the last quarter. Finally, Itau Unibanco Holding S.A. grew its position in Amrize by 150.0% during the fourth quarter. Itau Unibanco Holding S.A. now owns 750 shares of the company’s stock worth $41,000 after buying an additional 450 shares in the last quarter.
Amrize Trading Up 0.2%
Shares of AMRZ stock opened at $40.52 on Friday. The stock’s fifty day moving average price is $47.23 and its two-hundred day moving average price is $52.53. The company has a market cap of $22.41 billion, a PE ratio of 18.67, a P/E/G ratio of 1.20 and a beta of 0.04. Amrize Ltd has a fifty-two week low of $39.74 and a fifty-two week high of $65.94. The company has a debt-to-equity ratio of 0.33, a quick ratio of 0.73 and a current ratio of 1.10.
Amrize Announces Dividend
The business also recently announced a dividend, which was paid on Wednesday, August 26th. Stockholders of record on Tuesday, August 18th were issued a $0.11 dividend. The ex-dividend date of this dividend was Tuesday, August 18th. Amrize’s dividend payout ratio is 20.28%.
Insider Transactions at Amrize
In related news, insider Stephen S. Clark acquired 5,260 shares of the stock in a transaction that occurred on Tuesday, August 11th. The stock was acquired at an average cost of $47.31 per share, for a total transaction of $248,850.60. Following the transaction, the insider directly owned 10,637 shares in the company, valued at $503,236.47. This trade represents a 97.82% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Mario Gross bought 3,568 shares of the business’s stock in a transaction on Tuesday, August 11th. The stock was bought at an average price of $46.60 per share, for a total transaction of $166,268.80. Following the transaction, the insider directly owned 38,485 shares of the company’s stock, valued at approximately $1,793,401. This represents a 10.22% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. In the last three months, insiders have purchased 48,983 shares of company stock valued at $2,158,755. 0.54% of the stock is owned by company insiders.
Analysts Set New Price Targets
Several equities analysts have weighed in on the company. William Blair set a $40.00 price objective on Amrize in a report on Wednesday, September 2nd. DA Davidson assumed coverage on Amrize in a report on Monday, August 24th. They set a “neutral” rating and a $50.00 target price on the stock. Royal Bank Of Canada downgraded Amrize from a “sector perform” rating to an “underperform” rating and dropped their price target for the company from $60.00 to $48.00 in a research note on Monday, August 10th. Zacks Research cut shares of Amrize from a “hold” rating to a “strong sell” rating in a research report on Wednesday, August 19th. Finally, Weiss Ratings downgraded shares of Amrize from a “hold (c)” rating to a “hold (c-)” rating in a research note on Monday, August 31st. One investment analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, eight have given a Hold rating and four have issued a Sell rating to the company. According to MarketBeat.com, Amrize presently has a consensus rating of “Hold” and a consensus target price of $55.50.
View Our Latest Analysis on AMRZ
Amrize Company Profile
Amrize is a North American building materials and solutions company formed through the separation of Holcim’s North American business. The company began trading publicly on the New York Stock Exchange in 2025 under the symbol AMRZ.
Amrize supplies essential construction materials, including cement, aggregates, ready-mix concrete and asphalt. It also provides a range of building products and solutions used in residential, commercial and infrastructure construction, including concrete products, roofing systems and other materials designed to support building and construction projects.
The company serves customers across the United States and Canada through a network of production facilities, distribution operations and local businesses.
Featured Articles
- Five stocks we like better than Amrize
- Block Makes a Federal Trust Bank Move That Could Reshape Its Fintech Model
- Kroger’s Textbook Entry for Buy-and-Hold Investors
- AST SpaceMobile Looks to Extend Its 30-Day FCC Satellite Testing Window
- Amgen Drops 10% on a Trial It Didn’t Even Run
Want to see what other hedge funds are holding AMRZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amrize Ltd (NYSE:AMRZ – Free Report).
Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.
